Synthekine Stock

Develops engineered cytokine therapeutics for cancer and autoimmune disorders using targeted protein engineering.

Buy

Buy Synthekine shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Synthekine shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders.

Sector

Health Care

Founded

2018

Headquarters

Menlo Park, CA

Buy

Buy Synthekine shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Synthekine shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Synthekine Management Team

Synthekine people and management

  • Founder
    Christopher Garcia
  • CEO
    Debanjan Ray
  • Chief Development Officer
    Martin Oft
  • Chief Medical Officer
    Naiyer Rizvi
  • Board Member
    Nils Lonberg
  • Board Member
    Julie Grant
  • Board Member
    Mardi Dier
  • Board Member
    Pablo J. Cagnoni
  • Board Member
    Srinivas Akkaraju
  • Board Member
    Larry Lasky

Investors

Major Synthekine investors

  • TCG X

  • Samsara BioCapital

  • Rock Springs Capital

  • RA Capital Management

  • Omega Funds

  • Lilly Asia Ventures

  • Emerson Collective

  • Deerfield Management Company

  • Column Group

  • Canaan Partners

Synthekine Valuations & Financials

Gain Insights Into Synthekine Stock Valuation & Share Prices

View real-time NPM data on Synthekine stock including daily Synthekine stock price estimates, valuation history, and historical share price information. Access Synthekine financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Synthekine pricing across six independent market signals. Looking for private company due diligence data sources on Synthekine? Get in touch to learn more.

Similar Companies

Explore companies

like Synthekine

FAQ

Questions?

We have answers

Buy Synthekine Stock

Synthekine stock does not trade on public stock exchanges. Synthekine stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synthekine stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Synthekine Stock

Synthekine Stock does not trade on public stock exchanges. In order to sell Synthekine shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Synthekine Stock Price

Synthekine does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Synthekine share price and other valuable private market data.

Read more about secondary market private company stock prices:

Synthekine Stock Ticker Symbol

There is no ticker symbol for Synthekine stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Synthekine Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synthekine stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Synthekine Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synthekine stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Synthekine Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Synthekine IPO

Synthekine is a private company and has not had an IPO. There is currently no Synthekine IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Synthekine IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.